BlackRock Institutional Trust’s Calithera Biosciences, Inc CALA Stock Holding History

BlackRock Institutional Trust’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$848K	Buy	13,044 +1,515	+13%	+$94.6K	﹤0.01%	3333
2016 Q3	$749K	Sell	11,529 -12	-0.1%	-$774	﹤0.01%	3382
2016 Q2	$856K	Sell	11,541 -4,384	-28%	-$439K	﹤0.01%	3363
2016 Q1	$1.81M	Buy	15,925 +213	+1%	+$24.1K	﹤0.01%	3077
2015 Q4	$2.41M	Buy	15,712 +134	+0.9%	+$20.1K	﹤0.01%	3049
2015 Q3	$1.69M	Buy	15,578 +7,896	+103%	+$1.02M	﹤0.01%	3173
2015 Q2	$1.1M	Buy	+7,682	New	+$1.78M	﹤0.01%	3330

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Institutional Trust's CALA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Calithera Biosciences, Inc (CALA) stake by 13% in Q4 2016, buying an estimated $94.6K and bringing the position to 13,044 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

BlackRock Institutional Trust first reported a position in CALA in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.41M in Q4 2015. 33 funds tracked by Wall St. Rank hold CALA as of Q4 2016.

BlackRock Institutional Trust held 13,044 shares of Calithera Biosciences, Inc worth $848K as of Q4 2016.
BlackRock Institutional Trust bought 1,515 Calithera Biosciences, Inc shares in Q4 2016, an estimated $94.6K.
Calithera Biosciences, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3333 holding.
BlackRock Institutional Trust first reported a position in Calithera Biosciences, Inc in Q2 2015 and has held it in 7 quarters since.
BlackRock Institutional Trust's Calithera Biosciences, Inc position peaked at $2.41M in Q4 2015.
33 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.